Analysed MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) News Sources
Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026
18-03-2026
yahoo.com
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
13-02-2026
yahoo.com
Here's Why We're Watching Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation
26-01-2026
yahoo.com
What is the current price of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The current price of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is $0.464.
MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) since the previous trading day is $-0.0005.
MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) since the previous trading day is -0.1076%.
What is the most recent average sentiment score for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The most recent average sentiment score for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is 84 out of 100.
What is the most recent average sentiment for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The most recent sentiment for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is .
SEC-8K** Filing Available For MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.